Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Comparision between Indo US BioTech IPO and Vera Synthetic IPO.
Indo US BioTech IPO is a SME Fixed Price Issue IPO proposed to list at BSE SME while Vera Synthetic IPO is a SME Fixed Price Issue proposed to list at NSE SME.
| Indo US BioTech IPO | Vera Synthetic IPO | |
|---|---|---|
| Logo |  |
 |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price Issue | Fixed Price Issue |
| Listing At | BSE SME | NSE SME |
| Lead Managers | Swastika Investmart Ltd | Pantomath Capital Advisors Pvt Ltd |
| Registrar | Bigshare Services Pvt Ltd | Link Intime India Private Ltd |
| Market Maker | ||
| DRHP | DRHP  |
DRHP |
| RHP | RHP |
RHP |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL |
IPO Allotment URL |
The total issue size of Indo US BioTech IPO is up to ₹7.29 Cr whereas the issue size of the Vera Synthetic IPO is up to ₹5.34 Cr. The final issue price of Indo US BioTech IPO is ₹51.00 per share and of Vera Synthetic IPO is ₹40.00 per share.
| Indo US BioTech IPO | Vera Synthetic IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹51.00 per share | ₹40.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 2000 shares | 3000 shares |
| Fresh Issue Size | ||
| Fresh Issue Size (Amount) | ||
| OFS Issue Size | ||
| OFS Issue Size (Amount) | ||
| Issue Size Total | 14,30,000 shares | 13,35,000 shares |
| Issue Size Total (Amount) | up to ₹7.29 Cr | up to ₹5.34 Cr |
Indo US BioTech IPO opens on Apr 30, 2018, while Vera Synthetic IPO opens on Mar 28, 2018. The closing date of Indo US BioTech IPO and Vera Synthetic IPO is May 03, 2018, and Apr 04, 2018, respectively.
| Indo US BioTech IPO | Vera Synthetic IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Apr 30, 2018 | Mar 28, 2018 |
| Issue Close | May 03, 2018 | Apr 04, 2018 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | ||
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Indo US BioTech IPO P/E ratio is , as compared to Vera Synthetic IPO P/E ratio of .
| Indo US BioTech IPO | Vera Synthetic IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financial |
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Indo US BioTech IPO retail investors (RII) are offered 6,78,000 shares while in Vera Synthetic IPO retail investors are offered 6,78,000 shares. Qualified institutional buyers (QIB) are offered 0 shares in Indo US BioTech IPO and 0 shares in Vera Synthetic IPO.
| Indo US BioTech IPO | Vera Synthetic IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | 74,000 shares | 69,000 shares |
| QIB | 0 shares | 0 shares |
| NII | 6,78,000 shares | 6,33,000 shares |
| RII | 6,78,000 shares | 6,33,000 shares |
| Employee | ||
| Others | ||
| Total | 14,30,000 shares | 13,35,000 shares |
Indo US BioTech IPO subscribed 19.74x in total, whereas Vera Synthetic IPO subscribed 3.49x.
| Indo US BioTech IPO | Vera Synthetic IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 19.52x | 3.29x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 19.87x | 3.70x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 19.74x | 3.49x |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
